Title: A Retrospective Study of Incidence of Superficial Venous Thrombophlebitis in Long Saphenous Varicose Vein and its Surgical Significance in Preventing DVT

Authors: Dr K.Ravichandran, Dr R.Ramesh, Dr M.V.Pradeep Anand, Dr V Uvaraj

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i12.130

Abstract

Aim: To highlight the importance and emphasize the consequence of DVT and pulmonary embolism in superficial thrombophlebitis in long saphenous vein varicosities and the methodology to prevent them.

Objectives: To study the incidence in 1.sex, 2.age, 3.associated risk factors, 4.site of Superficial Thrombophlebitis in long saphenous vein, 6.management - surgical and medical management,.7. intra –operative findings,8.post operative study, 9.morbidity and 10.mortality.and the outcome in patients of Superficial venous Thrombophlebitis in long saphenous vein in Rajah Muthiah Medical College Hospital.

Keywords: superficial thrombophlebitis (STP), deep vein thrombosis [DVT], Pulmonary embolism, visceral neoplasm.

References

  1. Blumenberg RM, Barton E, Gelfand ML, Skudder P, Brennan J. Occult deep venous thrombosis complicating superficial thrombophlebitis. J Vasc Surg. 1998;27:338-43.
  2. Verlato F, Zucchetta P, Prandoni P, et al. An unexpectedly high rate of pulmonary embolism in patients with superficial thrombophlebitis of the thigh. J Vasc Surg. 1999;30:1113-5.        
  3. Schönauer V, Kyrle PA, Weltermann A, et al. Superficial thrombophlebitis and risk for recurrent thromboembolism. J Vasc Surg. 2003;37:834-8.       
  4. Samlaska CP, James WD. Superficial thrombophlebitis I. Primary hypercoagu-lable states. J Am Acad Dermatol. 1990;22(6 Pt 1):975-89.
  5. Samlaska CP, James WD. Superficial thrombophlebitis II. Secondary hypercoag-ulable states. J Am Acad Dermatol. 1990;23:1-18.
  6. Wahrenbrock M, Borsig L, Le D, Varki N, Varki A. Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest. 2003;112:853-62.
  7. Husni EA, Williams WA. Mondor´s disease. A superficial phlebitis of the breast. Lancet. 1962;1:994-6.
  8. Leon L, Giannoukas AD, Dodd D, Chan P, Labropoulos N. Clinical significance of superficial vein thrombosis. Eur J VascEndovasc Surg. 2005;29:10-7.
  9. Lutter KS, Kerr TM, Roedersheimer LR, Lohr JM, Sampson MG, Cranley JJ. Superficial thrombophlebitis diagnosed by duplex scanning. Surgery. 1991;110:42-6.
  10. Superficial Thrombophlebitis Treated By Enoxaparin Study Group. A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis. Arch Intern Med. 2003;163:1657-63.
  11. Lofgren EP, Lofgren KA. The surgical treatment of superficial thrombophlebitis. Surgery. 1981;90:49-54.
  12. Sullivan V, Denk PM, Sonnad SS, Eagleton MJ, Wakefield TW. Ligation versus anticoagulation: treatment of above-knee superficial thrombophlebitis not involving the deep venous system. J Am Coll Surg. 2001;193:556-62.       
  13. Lozano FS, Almazan A. Low-molecular-weight heparin versus saphenofemoral disconnection for the treatment of above-knee greater saphenous thrombophlebitis: a prospective study. Vasc Endovascular Surg. 2003;37:415-20.
  14. Di Nisio M, Wichers IM, Middeldorp S. Treatment for superficial thrombophlebitis of the leg. Cochrane Database Syst Rev. 2007(2):CD004982.      
  15. Marchiori A, Mosena L, Prandoni P. Superficial vein thrombosis: Risk factors, diagnosis, and treatment. Semin Thromb Hemost. 2006;32:737–743. 
  16. Gorty S, Patton-Adkins J, Dalanno M, Starr JE, Dean S, Satiani B. Superficial venous thrombosis of the lower extremities: Analysis of risk factors, and recurrence and role of anticoagulation.  Vasc Med. 2004;9:1–6. 
  17. Decousus H, Epinat M, Guillot K, et al. Superficial vein thrombosis risk factors, diagnosis and treatment. CurrOpinPulm Med. 2003;9:393–397.
  18. Sullivan V, Denk PM, Sonnad SS, Eagleton MJ, Wakefield TW. Ligation versus anticoagulation: Treatment of above-knee superficial thrombophlebitis not involving the deep venous system. J Am Coll Surg. 2001;193:556–562.
  19. Decousus H, Prandoni P, Mismetti P, et al. for the Calista Study Group. Fondaparinux in the treatment of superficial-vein thrombosis of the leg. N Engl J Med. 2010;363:1222–1232.
  20. Schonauer V, Kyrle PA, Weltermann A, et al. Superficial thrombophlebitis and risk for recurrent venous thromboembolism. J Vasc Surg. 2003;37:834–838. 

Corresponding Author

Dr K.Ravichandran

Associate Professor of Surgery

Dept of Surgery Rajah Muthiah Medical College,

Annamalai University, Annamalainagar, Chidambaram, Tamil Nadu